2020 U.S. Healthcare Policy and Election Outlook
Bloomberg Intelligence’s senior health-policy analyst Brian Rye discusses the ongoing drug-pricing and surprise-billing battles, as well as the implications of the upcoming U.S. elections.Contact David Oberacker [doberacker@bloomberg.net] or Michelle Pas [mpas1@bloomberg.net] to request a demo or speak with an analyst about any of the features discussed.
Speakers
Brian Rye
Senior Healthcare Policy Analyst
Bloomberg Intelligence
Brian Rye is a senior health care policy analyst for Bloomberg Intelligence. Mr. Rye covers the impact of Washington legislation and regulations on the health care industry. Prior to working with Bloomberg Intelligence, Mr. Rye was a Senior Healthcare Analyst with Bloomberg Government. He spent 12 years as an equity research analyst at SunTrust, Raymond James and Janney Montgomery Scott. In those capacities, he followed biotech, pharmaceutical and other health-care companies. Rye also served as a senior business management analyst for Booz Allen Hamilton’s civil health group. He received a bachelor’s degree in economics from Vanderbilt University and holds the Chartered Financial Analyst designation.